CARGO Therapeutics 的股票在公司宣布裁员90%后上涨。 CARGO Therapeutics 的股票在公司宣布裁员90%后上涨。 Benzinga03/19 20:29 领先的盘前涨幅股票 雷神能源控股(LSE)股票在周三开盘前飙升94%,延续了周二的涨势。MediWound(MDWD)股票上涨19%,此前公司报告了第四季度更高的营业收入。Cargo Therapeutics(CRGX) MT...
中文名: CARGO Therapeutics, Inc. 公司名称: Cargo Therapeutics, Inc. 所属行业: 健康科技 / 生物技术 交易所: 纳斯达克交易所 股票分析 最近更新于 2025-03-05 1 超过14%的股票 行业排名 262/283 市场排名 4225/4922 机构预测 当前价 $3.820 目标均价 $8.83 最高目标价 $33.00 最低目标价 $2....
用富途牛牛查看CARGO Therapeutics (CRGX)的股票价格、新闻、历史走势图、分析师评级、财务信息和行情。使用富途牛牛免佣金股票交易App进行交易。
CARGO Therapeutics, Inc. (CRGX) Upgraded to Buy: What Does It Mean for the Stock? Feb. 3, 2025 at 12:00 p.m. ETon Zacks.com Biotech Alert: Searches spiking for these stocks today Jan. 31, 2025 at 11:20 a.m. ETon TipRanks.com ...
CARGO Therapeutics, Inc. (CRGX) Upgraded to Buy: What Does It Mean for the Stock? Feb. 3, 2025 at 12:00 p.m. ET on Zacks.com Biotech Alert: Searches spiking for these stocks today Jan. 31, 2025 at 11:20 a.m. ET on TipRanks.com 12 Health Care Stocks Moving In Thursday...
See CARGO Therapeutics's detailed income statement and balance sheet. Find out their revenue, expenses and profit or loss over the last fiscal year.
CRGX Stock Earnings: Cargo Therapeutics Beats EPS for Q1 2024 CRGX Stock Earnings: Cargo Therapeutics Misses EPS for Q4 2023 More Articles Select Price, Percent change, or Dollar change as the y-axis. Price Select Area, Line, OHLC or Candlestick as the chart type. ...
CRGX Stock Price 1D 5D 1M 6M YTD 1Y 5Y 10Y MAX Basic Advanced -84.62% CARGO Therapeutics, Inc. price and volume Combination chart with 2 data series. Chart represents CARGO Therapeutics, Inc. price and volume over 1Y period The chart has 2 X axes displaying Time, and Time. The chart...
The upgrade of CARGO Therapeutics, Inc. to a Zacks Rank #2 positions it in the top 20% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move higher in the near term. Only $1 to See All Zacks' Buys and Sells ...
Stock Price 12.39 About CARGO Therapeutics CARGO Therapeutics (CRGX) operates as a biotechnology company that focuses on developing Chimeric Antigen Receptor (CAR) T-cell therapies for cancer treatment. The company's main offerings include engineering CAR T-cell therapies designed to overcome resistance...